Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee

被引:3
作者
Lautz, Timothy B. B. [1 ]
Xue, Wei [2 ]
Luo, Leo Y. Y. [3 ]
Fair, Douglas [4 ]
Qumseya, Amira [2 ]
Gao, Zhengya [2 ]
Dasgupta, Roshni [5 ]
Rodeberg, Dave [6 ]
Venkatramani, Rajkumar [7 ]
机构
[1] Northwestern Univ, Ann & Robert Lurie Childrens Hosp Chicago H, Dept Surg, Chicago, IL 60611 USA
[2] Univ Florida, Dept Biostat, Gainesville, FL USA
[3] Vanderbilt Univ, Dept Radiat Oncol, Med Ctr, Nashville, TN USA
[4] Univ Utah, Primary Childrens Hosp, Huntsman Canc Inst, Dept Pediat,Div Hematol Oncol, Salt Lake City, UT USA
[5] Cincinnati Childrens Med Ctr, Div Pediat Surg, Cincinnati, OH USA
[6] Univ Kentucky, Kentucky Childrens Hosp, Div Pediat Surg, Coll Med, Lexington, KY USA
[7] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX USA
关键词
pediatric oncology; radiation oncology; rhabdomyosarcoma; surgery; RISK RHABDOMYOSARCOMA; RADIOTHERAPY; EXCISION;
D O I
10.1002/pbc.30357
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Rhabdomyosarcoma (RMS) of the chest wall presents unique management challenges and local control considerations. The benefit of complete excision is uncertain and must be weighed against potential surgical morbidity. Our aim was to assess factors, including local control modality, associated with clinical outcomes in children with chest wall RMS.Methods: Forty-four children with RMS of the chest wall from low-, intermediate-, and high-risk Children's Oncology Group studies were reviewed. Predictors of local failure-free survival (FFS), event-free survival (EFS), and overall survival (OS) were assessed, including clinical characteristics and staging, primary tumor anatomic locations, and local control modalities. Survival was assessed by Kaplan-Meier analysis and the log-rank test.Results: Tumors were localized in 25 (57%) and metastatic in 19 (43%), and they involved the intercostal region (52%) or superficial muscle alone (36%). Clinical group was I (18%), II (14%), III (25%), and IV (43%), and ultimately 19 (43%) patients had surgical resection (upfront or delayed), including 10 R0 resections. Five-year local FFS, EFS, and OS were 72.1%, 49.3%, and 58.5%, respectively. Univariate factors associated with local FFS included age, International Rhabdomyosarcoma Study (IRS) group, extent of surgical excision, tumor size, superficial tumor location, and presence of regional or metastatic disease. Other than tumor size, the same factors were associated with EFS and OS.Conclusions: Chest wall RMS has variable presentation and outcome. Local control is a significant contributor to EFS and OS. Complete surgical excision, whether upfront or after induction chemotherapy, is usually only possible for smaller tumors confined to the superficial musculature but is associated with improved outcomes. While overall outcomes remain poor for patients with initially metastatic tumors, regardless of local control modality, complete excision may be beneficial for patients with localized tumors if it can be achieved without excess morbidity.
引用
收藏
页数:8
相关论文
共 15 条
[1]   Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803 [J].
Arndt, Carola A. S. ;
Stoner, Julie A. ;
Hawkins, Douglas S. ;
Rodeberg, David A. ;
Hayes-Jordan, Andrea A. ;
Paidas, Charles N. ;
Parham, David M. ;
Teot, Lisa A. ;
Wharam, Moody D. ;
Breneman, John C. ;
Donaldson, Sarah S. ;
Anderson, James R. ;
Meyer, William H. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) :5182-5188
[2]   Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group [J].
Casey, Dana L. ;
Chi, Yueh-Yun ;
Donaldson, Sarah S. ;
Hawkins, Douglas S. ;
Tian, Jing ;
Arndt, Carole A. ;
Rodeberg, David A. ;
Routh, Jonathan C. ;
Lautz, Timothy B. ;
Gupta, Abha A. ;
Yock, Torunn, I ;
Wolden, Suzanne L. .
CANCER, 2019, 125 (18) :3242-3248
[3]   Treatment and outcome of patients with localized intrathoracic and chest wall rhabdomyosarcoma: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS) [J].
Fuchs, Joerg ;
Urla, Cristian ;
Sparber-Sauer, Monika ;
Schuck, Andreas ;
Leuschner, Ivo ;
Klingebiel, Thomas ;
Blumenstock, Gunnar ;
Seitz, Guido ;
Koscielniak, Ewa .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (05) :925-934
[4]   An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials [J].
Haduong, Josephine H. ;
Heske, Christine M. ;
Allen-Rhoades, Wendy ;
Xue, Wei ;
Teot, Lisa A. ;
Rodeberg, David A. ;
Donaldson, Sarah S. ;
Weiss, Aaron ;
Hawkins, Douglas S. ;
Venkatramani, Rajkumar .
PEDIATRIC BLOOD & CANCER, 2022, 69 (04)
[5]   Implications of Tumor Characteristics and Treatment Modality on Local Recurrence and Functional Outcomes in Children With Chest Wall Sarcoma A Pediatric Surgical Oncology Research Collaborative Study [J].
Harris, Courtney J. ;
Helenowski, Irene ;
Murphy, Andrew J. ;
Mansfield, Sara A. ;
LaQuaglia, Michael P. ;
Heaton, Todd E. ;
Cavalli, Michele ;
Murphy, Joseph T. ;
Newman, Erika A. ;
Overmen, Richard E. ;
Kartal, Tanvi T. ;
Cooke-Barber, J. ;
Donaher, Addison ;
Malek, Marcus M. ;
Kalsi, Ranjeet ;
Kim, Eugene S. ;
Zobel, Michael J. ;
Goodhue, Catherine J. ;
Naik-Mathuria, Bindi J. ;
Jefferson, Imory N. ;
Roach, Jonathan P. ;
Mata, Claudia ;
Piche, Nelson ;
Joharifard, Shahrzad ;
Sultan, Serge ;
Short, Scott S. ;
Meyers, Rebecka L. ;
Bleicher, Josh ;
Le, Hau D. ;
Janek, Kevin ;
Butter, Andreana ;
Davidson, Jacob ;
Aldrink, Jennifer H. ;
Richards, Holden W. ;
Tracy, Elisabeth T. ;
Commander, Sarah J. ;
Fialkowski, Elizabeth A. ;
Troutt, Misty ;
Dasgupta, Roshni ;
Lautz, Timothy B. .
ANNALS OF SURGERY, 2022, 276 (06) :E969-E975
[6]   Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group [J].
Hawkins, Douglas S. ;
Chi, Yueh-Yun ;
Anderson, James R. ;
Tian, Jing ;
Arndt, Carola A. S. ;
Bomgaars, Lisa ;
Donaldson, Sarah S. ;
Hayes-Jordan, Andrea ;
Mascarenhas, Leo ;
McCarville, Mary Beth ;
McCune, Jeannine S. ;
McCowage, Geoff ;
Million, Lynn ;
Morris, Carol D. ;
Parham, David M. ;
Rodeberg, David A. ;
Rudzinski, Erin R. ;
Shnorhavorian, Margarett ;
Spunt, Sheri L. ;
Skapek, Stephen X. ;
Teot, Lisa A. ;
Wolden, Suzanne ;
Yock, Torunn I. ;
Meyer, William H. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (27) :2770-+
[7]   The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the children's oncology group [J].
Hayes-Jordan, Andrea ;
Stoner, Julie A. ;
Anderson, James R. ;
Rodeberg, David ;
Weiner, Gene ;
Meyer, William H. ;
Hawkins, Doug S. ;
Arndt, Carota A. S. ;
Paidas, Charles .
JOURNAL OF PEDIATRIC SURGERY, 2008, 43 (05) :831-836
[8]  
Howlander N., 2016, SEER Cancer Statistics Review, 1975-2014
[9]   Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group (COG) [J].
Lautz, Timothy B. ;
Chi, Yueh-Yun ;
Li, Minjie ;
Wolden, Suzanne L. ;
Casey, Dana L. ;
Routh, Jonathan C. ;
Granberg, Candace F. ;
Binite, Odion ;
Rudzinski, Erin R. ;
Hawkins, Douglas S. ;
Venkatramani, Rajkumar ;
Rodeberg, David A. .
CANCER, 2021, 127 (02) :275-283
[10]   Outcomes of chest wall resections in pediatric sarcoma patients [J].
Lopez, Carmen ;
Correa, Arlene ;
Vaporciyan, Ara ;
Austin, Mary ;
Rice, David ;
Hayes-Jordan, Andrea .
JOURNAL OF PEDIATRIC SURGERY, 2017, 52 (01) :109-114